Fonte: BMC Medical Genomics. Unidade: FM
Assuntos: NEOPLASIAS RETAIS (TERAPIA), BIÓPSIA, BIOMARCADORES, RADIOTERAPIA, CO-TERAPIA
ABNT
RAMOS, Camila Ramos et al. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. BMC Medical Genomics, 2014Tradução . . Disponível em: https://doi.org/10.1186/s12920-014-0068-7. Acesso em: 04 out. 2024.APA
Ramos, C. R., Habr Gama, A., Quevedo, B. de S., Felício N.,, Bettoni, F., Koyama, F. C., et al. (2014). Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. BMC Medical Genomics. doi:10.1186/s12920-014-0068-7NLM
Ramos CR, Habr Gama A, Quevedo B de S, Felício N., Bettoni F, Koyama FC, Arprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, Perez RO, Parmigiani RB. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients [Internet]. BMC Medical Genomics. 2014 ;[citado 2024 out. 04 ] Available from: https://doi.org/10.1186/s12920-014-0068-7Vancouver
Ramos CR, Habr Gama A, Quevedo B de S, Felício N., Bettoni F, Koyama FC, Arprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, Perez RO, Parmigiani RB. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients [Internet]. BMC Medical Genomics. 2014 ;[citado 2024 out. 04 ] Available from: https://doi.org/10.1186/s12920-014-0068-7